T1	Participants 40 70	sleep apnea/hypopnea syndrome.
T2	Participants 276 312	sleep apnea/hypopnea syndrome (SAHS)
T3	Participants 466 553	Fifty-five patients suspected of having SAHS and living within 30 km of our laboratory.
T4	Participants 562 604	Patients were studied first in their homes
